Methotrexate and Hepatic Toxicity in Rheumatoid Arthritis and Psoriatic Arthritis

Author： Tilling Lindsey Townsend Sue David Joel

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.26, Iss.2, 2006-01, pp. : 55-62

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The pharmacokinetic effect of coadministration of apremilast and methotrexate in individuals with rheumatoid arthritis and psoriatic arthritis

Clinical Pharmacology In Drug Development, Vol. 3, Iss. 6, 2014-11 ,pp. : 456-465

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sulfasalazine + methotrexate beneficial for rheumatoid arthritis

Inpharma, Vol. 1, Iss. 1577, 2007-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Methotrexate improves survival in rheumatoid arthritis

Inpharma, Vol. 1, Iss. 1333, 2002-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

An update on methotrexate pharmacogenetics in rheumatoid arthritis

By Ranganathan Prabha

Pharmacogenomics, Vol. 9, Iss. 4, 2008-04 ,pp. : 439-451

Future Medicine

Access to resources Recommend Favorite

Biologic Battlefields: Changes in the US Markets for Rheumatoid Arthritis and Psoriatic Arthritis

Pharmaceutical & Diagnostic Innovation, Vol. 1, Iss. 3, 2004-01 ,pp. : 16-20

Adis International

Access to resources Recommend Favorite